Paul Industries delivers validation and commissioning in Connecticut for pharmaceutical, biotech, clinical supply, sterile compounding and research facilities, carrying utilities, process equipment and controlled rooms from start-up through IQ, OQ and PQ to a released, documented system. Connecticut combines the research campuses of large drug makers with a growing base of New Haven biotech companies, a state registration requirement for drug manufacturers and state inspection of sterile compounding rooms, so a Connecticut program answers to FDA and to state agencies at once. Paul Industries runs commissioning and qualification under one contract and is headquartered at 256 Shore Drive, Kilmarnock, Virginia.
Request a quote or call 201-450-8280
What does validation and commissioning in Connecticut cover?
Validation and commissioning in Connecticut covers the engineering proof that a new or modified system was installed as designed and works across its range (commissioning), and the documented GMP evidence that it is fit for its intended use (installation, operational and performance qualification). The systems in question range from purified water and clean steam loops, CIP and SIP skids, autoclaves, bioreactors and process vessels to cleanroom air handling, controlled temperature storage and the automation that runs them.
Paul Industries writes and executes the documents: user requirements, design review, factory and site acceptance tests, commissioning checklists and functional tests, each IQ OQ PQ protocol with its acceptance criteria, deviation reports and the summary reports that release the system. The national scope of the service, including protocol content and requalification, is set out on the validation and commissioning page. This page covers what Connecticut sites, Connecticut statutes and the Connecticut industry mix add.
Pharmaceutical companies in Connecticut and where qualification work sits
Pharmaceutical companies in Connecticut cluster in three places: the Pfizer research campus in Groton, the Boehringer Ingelheim United States headquarters and research site in Ridgefield, and a New Haven biotech district that includes Alexion, AstraZeneca Rare Disease and Arvinas, with genomic research at The Jackson Laboratory in Farmington. When people ask what pharmaceutical companies are in Connecticut, those names come first, but the qualification work also reaches contract manufacturers, medical device and personal care plants, hospital pharmacies and university laboratories across the state.
| Company and site | What the site does | Typical systems in a CQV program |
|---|---|---|
| Pfizer, Groton | 175-acre research campus; Global Clinical Supply; manufacturing technology center for clinical-stage material announced in 2026 | Multi-product process equipment, solvent and clean utilities, controlled storage, laboratory systems |
| Boehringer Ingelheim, Ridgefield | United States headquarters and one of the company’s main research and development sites | Laboratory utilities, pilot equipment, environmental chambers, building management systems |
| Alexion, AstraZeneca Rare Disease, New Haven | Research facility at 100 College Street | Laboratory water and gases, cold storage, biosafety cabinets, controlled rooms |
| Arvinas, New Haven | Headquarters at Science Park; protein degrader research, including vepdegestrant with Pfizer | Laboratory equipment and storage qualification, analytical systems |
| The Jackson Laboratory, Farmington | 189,000 square foot genomic medicine research facility | Research building commissioning, vivarium environment, freezers and laboratory utilities |
Pharma companies Connecticut hosts, from Groton to Ridgefield
The pharma companies Connecticut hosts lean toward research, development and clinical supply rather than large commercial fill and finish, and that mix shapes the qualification work. Research buildings need commissioning that proves performance without a GMP label, while clinical supply and pilot plants need GMP qualification scaled to their phase. The biotech companies Connecticut has drawn to New Haven add a third pattern: suites that start as research space and later take on GMP work, so their first commissioning records become the foundation of a later qualification.
A pharmaceutical company in Ridgefield, Connecticut, a startup in a New Haven incubator and a clinical supply group in Groton therefore ask for different depth from the same service. Paul Industries sizes each program to the decision the records must support, from a commissioning report for a research freezer farm to a full IQ, OQ and PQ for a process train that will make trial material.
Clinical supply at Groton and multi-product suites
Clinical supply manufacturing makes the drug substance and drug product used in trials, and in Connecticut its center of gravity is Groton, where Pfizer runs Global Clinical Supply and announced in November 2026 a 650 million dollar, 220,000 square foot manufacturing technology center to make clinical-stage ingredients and products, with construction planned from the second quarter of 2027 and operations in mid-2031. Pharmaceutical companies in Groton, CT and their suppliers run equipment that changes product often, sometimes weekly.
Multi-product equipment changes what qualification has to prove. Cleaning and changeover become as important as capacity: the OQ shows that CIP or manual cleaning reaches every surface, that sample points and swab locations represent the worst case, and that hold times between use and cleaning are defined. Equipment for first-in-human material may fall under the phase 1 exemption from Part 211 in 21 CFR 210.2(c), with controls set out in FDA’s 2008 guidance, while later-phase material moves toward full Part 211 qualification. Paul Industries writes the qualification so it can grow with the program instead of being rewritten at each phase.
Connecticut drug manufacturer registration beside FDA qualification
Connecticut requires a drug, device or cosmetic manufacturer located in the state to hold a certificate of registration from the Commissioner of Consumer Protection before it operates, renewed every year, under section 21a-70 of the General Statutes. The statute’s definition of a manufacturer covers producing, preparing, compounding, processing, packaging and labeling, so a new packaging line or a repurposed suite can bring a site into the registration as well as into FDA’s registration and inspection system.
| Requirement | Who it applies to | What the qualification records must show |
|---|---|---|
| FDA cGMP, 21 CFR 210 and 211 | Drug manufacturers, including clinical supply beyond phase 1 | Equipment of appropriate design, cleaning procedures, calibrated and checked automatic equipment |
| 21 CFR Part 11 | Sites keeping GMP records electronically | Audit trails, access control, electronic signatures tested in the OQ |
| CGS 21a-70 registration | In-state manufacturers of drugs, devices or cosmetics | A facility and process ready for the registered activity; renewal each year |
| CGS 20-633b | Sterile compounding pharmacies, including hospital pharmacies starting sterile work | Rooms and hoods meeting USP 797 and 800 before the state inspection |
| RCSA 29-232-4 boiler certificates | Steam and hot water boilers feeding autoclaves, clean steam and process heat | Current boiler certificate filed with the utility IQ |
| 2022 Connecticut State Building Code | Permitted new construction and alterations | Energy code commissioning of building systems alongside GMP qualification |
Sterile compounding rooms in Connecticut hospitals and pharmacies
A sterile compounding pharmacy in Connecticut, including a hospital pharmacy that begins sterile compounding for the first time, starts that work only after the Department of Consumer Protection has inspected the premises and approved its application addendum, under section 20-633b of the General Statutes. The statute ties sterile compounding to USP chapters 797, 800 and 825, which set the room classifications, pressure relationships, air change and certification requirements the rooms must meet.
The engineering side of that inspection is a qualification exercise. Paul Industries commissions the air handling, HEPA filtration, pressure cascades and room monitoring, then certifies the rooms and hoods: HEPA filter integrity tests, airflow and air change measurements, airflow visualization at the critical sites, particle counts for ISO 14644-1 classification, and documented pressure differentials between the buffer room, ante room and the negative pressure hazardous drug room. USP 797 calls for certification of primary and secondary engineering controls at least every six months, so the first certification also sets the baseline for every recertification. Room construction is covered on cleanrooms in Connecticut.
Research laboratories and vivaria: commissioning without a GMP label
Research laboratories and vivaria in Connecticut, from New Haven and Farmington to Ridgefield and Groton, need commissioning that proves their environment and safety systems work, even where no GMP qualification applies. Fume hood exhaust, room pressurization, laboratory gases, freezer farms, emergency power transfer and vivarium temperature, humidity and light cycles are tested against the owner’s project requirements, because research data depend on them.
Commissioning services for these buildings follow the owner’s project requirements and basis of design, with functional tests of every sequence and trend data under real load. Where a research suite may later host GMP work, Paul Industries writes the commissioning tests and records to good engineering practice standards that a later qualification can reference, which saves repeating tests. Energy code commissioning of permitted building systems follows the 2022 Connecticut State Building Code, described for data halls on data center commissioning in Connecticut.
Steam, autoclaves and Connecticut boiler certificates
Steam systems that feed autoclaves, clean steam generators, SIP circuits and process heat in Connecticut start at boilers that need current state inspection certificates, issued annually for power boilers and every two years for low pressure heating boilers under section 29-232-4 of the state boiler regulations. A utility IQ for clean steam or an autoclave records the supplying boiler’s certificate, the pressure vessel nameplate and data report of the autoclave or generator, and the safety relief valve settings.
OQ and PQ for steam-dependent equipment then prove what the product sees: autoclave chamber temperature distribution and heat penetration, clean steam quality tests for non-condensable gases, superheat and dryness, and SIP cycles reaching temperature at the coldest point of each circuit. Boiler work that comes up during qualification is covered on boiler repair in Connecticut, and SIP circuits on CIP and SIP systems in Connecticut.
Freezers, cold rooms and incubators: mapping at Connecticut research sites
Freezers, cold rooms, incubators and stability chambers at Connecticut research and clinical supply sites are qualified by temperature mapping, which places calibrated data loggers through the storage volume to find the warmest and coldest points and to prove the unit holds its range when loaded, opened and recovering from a power interruption. The mapping study defines where the permanent monitoring probe belongs, so routine alarms reflect the worst location rather than a convenient one.
A typical study maps the empty unit, then a loaded unit, and adds door-open and power-off tests that show how long product stays in range before an alarm must be answered. Walk-in cold rooms and warehouses are mapped in the warmest and coldest parts of the year, since a Connecticut summer and a Connecticut January load the refrigeration and the building envelope very differently. Freezer farms at genomic and biotech sites add a second question: whether the room’s air conditioning can carry the heat rejected by dozens of ultra-low freezers, which Paul Industries checks during commissioning before the mapping begins.
Part 11 testing for controls, historians and environmental monitoring
Part 11 testing for controls, historians and environmental monitoring systems proves that electronic GMP records are attributable, secure and complete: user accounts and roles are tested, audit trails are shown to capture every change with the user, time and reason, electronic signatures are linked to their records, and backups are restored to prove they work. These tests sit in the OQ of the automated system and follow a risk-based approach consistent with GAMP 5.
Connecticut projects often join new equipment to an existing site historian or monitoring system, so the qualification also covers the interface: tag names, time synchronization, alarm routing and data transfer are tested end to end, and the change to the existing validated system goes through the site’s change control. Paul Industries writes those interface tests into the same protocol set as the equipment, so release of the new system and the update of the existing one are reviewed together.
Running qualification inside an occupied Connecticut building
Running qualification inside an occupied Connecticut building means testing new systems while neighboring labs, suites and production areas keep working, which turns scheduling and change control into part of the protocol. Shared air handlers, chilled water, process gases and purified water headers go through worst-case tests only with notice to their users, so every test that touches a shared utility is booked with the building’s facilities and quality staff, with a fallback position and a defined return to normal.
Shutdown windows for tie-ins to qualified utilities are planned with an impact assessment of each connected user, and post-work sampling or retesting is scheduled before those users resume GMP work. Paul Industries publishes a look-ahead of every test that affects shared systems, so a research group in the next suite learns about a pressure test or a water sanitization a week ahead rather than the morning it starts.
From equipment qualification to process validation
Equipment qualification is the foundation for process validation, which FDA’s 2011 guidance divides into three stages: process design, process qualification, and continued process verification. Qualified equipment and utilities are a prerequisite for the process performance qualification batches in stage two, so any open deviation, unapproved protocol or missing calibration on a system holds up the first commercial or late-phase campaign.
Connecticut sites moving a product from Groton or New Haven development toward commercial supply therefore plan the two together. The equipment qualification proves operating ranges wide enough to cover the process ranges in the batch record, the cleaning qualification covers the products that will share the equipment, and the monitoring set up during PQ becomes the data stream for continued process verification. Paul Industries maps each qualified range against the process parameters before protocols are approved, so every qualified range already covers what the process validation plan needs.
Which records does a Connecticut quality unit sign, stage by stage?
A Connecticut quality unit signs the records that define and release a system: the user requirements, the qualification plan, each protocol before execution, every deviation, and each summary report, while engineering signs the commissioning documents that feed them. Agreeing which commissioning tests count toward qualification, an approach set out in ASTM E2500 and the ISPE commissioning and qualification guide, keeps tests from being run twice.
| Stage | Main records | Signed by |
|---|---|---|
| Requirements and risk | User requirements, system impact and risk assessments, qualification plan | Quality unit and system owner |
| Design review | Design qualification or design review report, traceability matrix | Engineering and quality unit |
| Factory and site acceptance | FAT and SAT protocols and results, punch lists | Engineering; quality unit where leveraged |
| Commissioning | Installation checklists, start-up records, functional tests, calibration certificates | Engineering |
| IQ and OQ | Approved protocols, executed results, deviations and resolutions | Quality unit |
| PQ and release | Performance data over the defined period, summary report, release memo | Quality unit |
| Periodic review | Change records, trend reviews, requalification decisions | Quality unit and system owner |
Water and clean utility qualification for Connecticut suites
Water and clean utility qualification for Connecticut suites proves that purified water, water for injection, clean steam, process gases and compressed air reach every point of use at the specified quality, and it usually takes longer than any other system because PQ needs sampling over time. A purified water loop typically runs an intensive sampling phase at every point of use, then an extended phase that covers routine use, with results reviewed before water is released for production.
Feed water from surface reservoirs can shift in temperature, organic load and chlorination through the year, so a long PQ period that spans seasons gives confidence the pretreatment handles the whole range. Process gases are qualified for purity, moisture, particles and microbial content at the point of use, and compressed air in product contact for oil, water and particles. Water system design and construction are covered on ultrapure water systems in Connecticut, and the stainless distribution piping on process piping in Connecticut.
What does validation and commissioning in Connecticut cost?
Validation and commissioning in Connecticut cost what the number of systems, their GMP impact, the depth of testing and the state of existing records make them cost, so a firm price follows a system list and a qualification plan. A single freezer or incubator might need a short protocol set and a day of mapping, while a new water system or a multi-product process train needs months of protocol writing, execution and sampling.
| Factor | Lower effort | Higher effort |
|---|---|---|
| Existing records | Current drawings, vendor turnover packages and calibration records | Retrospective qualification with walkdowns and field verification |
| GMP impact | Research or indirect impact systems commissioned to good engineering practice | Direct impact systems needing full IQ, OQ and PQ |
| Leveraged testing | Commissioning and SAT accepted toward IQ and OQ | Every test repeated under GMP protocols |
| PQ duration | Single runs or short mapping studies | Water and clean steam sampling across weeks and seasons |
| Automation | Standalone equipment with simple controls | Integrated controls, historian interfaces and Part 11 testing |
Three factors move the price most: whether design and installation records exist and match the system, how much commissioning can be leveraged into IQ and OQ, and how long PQ sampling must run. Retrospective work on an older Connecticut facility whose drawings were never updated costs more than qualification planned from design. Paul Industries offers pharmaceutical validation services as a stand-alone program, as design-build with the system it supplies, or as complete installation through qualification and release. Send the system list, drawings and any existing records for a budget range and then a firm price.
Who performs validation and commissioning in Connecticut?
Paul Industries performs validation and commissioning in Connecticut for pharmaceutical, biotech, clinical supply, sterile compounding, medical device and research sites in New Haven, Groton, Ridgefield, Farmington, Hartford, Stamford and the rest of the state, qualifying systems it builds and systems built by any supplier. Connecticut life sciences companies receive one team accountable for commissioning, protocols, execution and release records under one contract and one schedule.
Once based in northern New Jersey and later Pennsylvania, Paul Industries now operates from its Kilmarnock, Virginia headquarters and takes qualification work across Connecticut and the Northeast, in all 50 states and at plants outside the United States. The same service in its headquarters state is described on validation and commissioning in Virginia, and in a neighboring state on validation and commissioning in New York. Every service offered in the state is listed on the Connecticut page.
Paul Industries qualification work at Connecticut sites
Paul Industries commissions and qualifies utilities, process equipment, cleanrooms, compounding rooms, autoclaves and controlled storage at Connecticut sites, from requirements and risk assessment through IQ, OQ, PQ, summary reports and periodic review. Send the system list and project schedule and request a quote to plan the program.
Standards referenced: 21 CFR Parts 210 and 211 (cGMP) · 21 CFR Part 11 · FDA Guidance: Process Validation, General Principles and Practices (2011) · ASTM E2500 · ISPE Baseline Guide Volume 5: Commissioning and Qualification · EU GMP Annex 15 · USP 797, 800 and 825 · ISO 14644-1 · Connecticut General Statutes section 21a-70 (drug manufacturer registration) · Connecticut General Statutes section 20-633b (sterile compounding pharmacies) · RCSA 29-232-4 (boiler inspection certificates)
Frequently asked questions
Does Paul Industries qualify systems for biotech companies in New Haven?
Paul Industries qualifies systems for biotech companies in New Haven, including laboratory water and gases, cold storage, biosafety cabinets, controlled rooms and pilot process equipment in Science Park, the medical district and the downtown research towers. Many New Haven suites move from research to GMP use over time, so commissioning records are written to a standard a later IQ can reference, saving repeat testing when the suite changes role.
Who provides commissioning and qualification at Groton, New London and southeastern Connecticut sites?
Paul Industries provides commissioning and qualification at research, clinical supply and manufacturing sites in Groton, New London, Norwich and Waterford. Clinical supply work there brings multi-product equipment, frequent changeovers and cleaning verification into the qualification, and Paul Industries writes protocols that can expand from early-phase controls to full Part 211 qualification as a program advances.
Who handles CQV in Ridgefield, Danbury and Fairfield County?
Paul Industries handles CQV in Ridgefield, Danbury, Stamford, Norwalk and Fairfield County for pharmaceutical research sites, personal care and device plants and hospital pharmacies. Research campuses there need commissioning of laboratory utilities, environmental chambers and building systems, while regulated production areas need IQ, OQ and PQ, and both are planned under one schedule so shared utilities are tested once.
Does Paul Industries commission and qualify systems in Hartford, Farmington and the Connecticut River Valley?
Paul Industries commissions and qualifies systems in Hartford, Farmington, Windsor and the rest of the Connecticut River Valley for hospital pharmacies, genomic and university research buildings, and device and nutraceutical plants. Typical work includes sterile compounding room certification, freezer and incubator mapping, vivarium environment commissioning and water system qualification.
What pharmaceutical companies are in Connecticut, and which systems do they qualify?
Connecticut’s best known pharmaceutical companies include Pfizer in Groton, Boehringer Ingelheim in Ridgefield, Alexion, AstraZeneca Rare Disease and Arvinas in New Haven, with The Jackson Laboratory in Farmington on the research side. Their sites qualify laboratory utilities and storage, pilot and clinical supply equipment, clean utilities and controlled rooms, alongside contract manufacturers, device makers and hospital pharmacies across the state.
Does a new Connecticut drug manufacturing suite need state registration as well as FDA registration?
A new Connecticut drug manufacturing suite needs a certificate of registration from the Commissioner of Consumer Protection under section 21a-70 of the General Statutes before it operates, renewed every year, in addition to FDA establishment registration where that applies. The state definition of manufacturer includes preparing, processing, packaging and labeling, so a qualification schedule should leave room for the registration steps before the first GMP batch.
What has to be ready before a Connecticut hospital pharmacy starts sterile compounding?
Before a Connecticut hospital pharmacy starts sterile compounding for the first time, its rooms and hoods must meet USP 797, and USP 800 where hazardous drugs are handled, and the Department of Consumer Protection must inspect the premises and approve the application addendum under section 20-633b. That means HEPA integrity tests, air change and pressure measurements, airflow visualization and ISO 14644-1 particle counts are finished and documented before the inspection date.
How often are sterile compounding rooms recertified in Connecticut?
Sterile compounding rooms and hoods in Connecticut are recertified at least every six months under USP 797, which the state ties to sterile compounding through section 20-633b, and again after any change that could affect airflow, such as filter replacement, equipment relocation or air handler repairs. Paul Industries keeps the first certification as the baseline and trends each later result against it.
What does a sterile compounding pharmacy need from its HVAC commissioning?
A sterile compounding pharmacy needs HVAC commissioning that proves the air handler delivers the designed air changes, the HEPA filters are intact, the room pressure cascade holds when doors open and close, the hazardous drug room stays negative to its surroundings, and alarms report pressure, temperature and humidity excursions. Those results feed directly into the room certification the state inspection relies on.
How is clinical supply equipment qualified when it makes several products?
Clinical supply equipment that makes several products is qualified with cleaning and changeover at the center: the OQ proves cleaning cycles reach every surface, sample and swab points cover the hardest-to-clean locations, and dirty and clean hold times are defined. Product-specific limits come from the cleaning validation program. Paul Industries builds those tests into the equipment qualification so a new product adds a short assessment rather than a new protocol.
Can research building commissioning records be reused in a later GMP qualification?
Research building commissioning records can be reused in a later GMP qualification when they were written to good engineering practice: approved test procedures, calibrated instruments, recorded results and controlled changes. Under ASTM E2500 and the ISPE commissioning and qualification guide, the quality unit can then accept those tests and the IQ verifies rather than repeats them. Paul Industries writes Connecticut research commissioning to that standard from the start.
Which boiler records belong in an autoclave or clean steam IQ in Connecticut?
An autoclave or clean steam IQ in Connecticut should include the current state inspection certificate of the boiler that supplies plant steam, annual for power boilers and biennial for low pressure heating boilers, the ASME nameplate and data report of the autoclave chamber or clean steam generator, relief valve settings and test records, and the steam and condensate drawings verified against the installation.
How much does validation cost for one autoclave or water loop in Connecticut?
How much validation costs for one autoclave or water loop in Connecticut depends on whether design and installation records exist, how many loads or points of use must be tested, and how long PQ sampling runs. An autoclave program centers on load patterns and heat penetration runs; a water loop on weeks of sampling across every point of use. Paul Industries prices each from the system list and existing records, budget first and firm once scope is set.
What should an IQ OQ PQ protocol for a Connecticut site include?
An IQ OQ PQ protocol for a Connecticut site should state its purpose and scope, the system boundary, the requirements each test traces to, prerequisites, test instruments and their calibration, step-by-step test instructions, objective acceptance criteria, data recording forms, deviation handling and approval signatures. Where state requirements apply, such as a boiler certificate or a compounding room standard, the protocol names them as verification points.
How long does qualification take for a new Connecticut clean utility system?
Qualification of a new Connecticut clean utility system usually runs several months from protocol approval to release, set mostly by PQ sampling. Commissioning and IQ can follow mechanical completion within weeks when records are current; OQ follows once controls are stable; water PQ then runs an intensive phase and an extended phase before production use. Planning protocols during construction keeps the schedule from stretching at the end.
Does Paul Industries qualify systems that other suppliers built at a Connecticut site?
Paul Industries qualifies systems that other suppliers built at Connecticut sites, starting with a walkdown against the drawings, a records gap assessment and any missing installation verifications, then commissioning tests where start-up data are incomplete, followed by IQ, OQ and PQ. Gaps are closed with field verification and documented rationale so the quality unit can release the system with a complete package.
What should a Connecticut site send to start a validation and commissioning proposal?
A Connecticut site should send its system list, process and instrumentation drawings or layouts, user requirements if written, the quality unit’s validation procedures, any vendor turnover packages, and the target release dates. For compounding rooms, include the room layout and the planned inspection date. Call 201-450-8280 or use the quote form, and Paul Industries returns a scope and schedule.
Qualifying new systems at a Connecticut site?
Send the system list, drawings, your validation procedures and the target release dates. Call 201-450-8280 or request a quote.
